| 来源类型 | Article
|
| 规范类型 | 评论
|
| Pain patients get relief from regulation |
| Sally Satel
|
| 发表日期 | 2019-04-15
|
| 出版年 | 2019
|
| 语种 | 英语
|
| 摘要 | In a span of 24 hours, the prospects for chronic pain patients treated with opioid medication vastly improved. On April 9, the Food and Drug Administration made official what hundreds of doctors have been saying for years: Patients whose intractable pain is being treated with opioids should move off them slowly, if they are to be tapered at all.
The agency said it received reports of “uncontrolled pain, psychological distress, and suicide” among patients who have become dependent on opioids when that medication is suddenly “discontinued or the dose rapidly decreased.” With serious withdrawal symptoms or increased pain, the agency instructed, it may even be necessary to return the opioid painkiller to its prior dosage and, once the person’s mental and physical state stabilizes, resume reducing the patient’s opioid usage more gradually.
Patients’ dosages are being too quickly reduced, often against their will, because of a tragic misapplication of the 2016 Guideline for Prescribing Opioids for Chronic Pain from the Centers for Disease Control and Prevention.
Read More
Patients’ dosages are being too quickly reduced, often against their will, because of a tragic misapplication of the 2016 Guideline for Prescribing Opioids for Chronic Pain from the Centers for Disease Control and Prevention. |
| 主题 | Health Care
|
| 标签 | addiction
; Opioid crisis
|
| URL | https://www.aei.org/articles/pain-patients-get-relief-from-regulation/
|
| 来源智库 | American Enterprise Institute (United States)
|
| 资源类型 | 智库出版物
|
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/265715
|
推荐引用方式
GB/T 7714 |
Sally Satel. Pain patients get relief from regulation. 2019.
|
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
